TEMPUS AI INC-CL A (TEM) Stock Price & Overview

NASDAQ:TEM • US88023B1035

Current stock price

50.84 USD
-0.04 (-0.08%)
At close:
50.7313 USD
-0.11 (-0.21%)
After Hours:

The current stock price of TEM is 50.84 USD. Today TEM is down by -0.08%. In the past month the price decreased by -3.27%. In the past year, price decreased by -0.99%.

TEM Key Statistics

52-Week Range36.22 - 104.32
Current TEM stock price positioned within its 52-week range.
1-Month Range48.75 - 62
Current TEM stock price positioned within its 1-month range.
Market Cap
9.089B
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.61
Dividend Yield
N/A

TEM Stock Performance

Today
-0.08%
1 Week
-0.12%
1 Month
-3.27%
3 Months
-21.13%
Longer-term
6 Months -42.38%
1 Year -0.99%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

TEM Stock Chart

TEMPUS AI INC-CL A / TEM Daily stock chart

TEM Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to TEM. When comparing the yearly performance of all stocks, TEM is a bad performer in the overall market: 78.24% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

TEM Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to TEM. Both the profitability and financial health of TEM have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TEM Earnings

On February 24, 2026 TEM reported an EPS of -0.04 and a revenue of 367.21M. The company beat EPS expectations (5.3% surprise) and beat revenue expectations (0.36% surprise).

Next Earnings DateMay 1, 2026
Last Earnings DateFeb 24, 2026
PeriodQ4 / 2025
EPS Reported-$0.04
Revenue Reported367.211M
EPS Surprise 5.30%
Revenue Surprise 0.36%

TEM Forecast & Estimates

23 analysts have analysed TEM and the average price target is 88.09 USD. This implies a price increase of 73.27% is expected in the next year compared to the current price of 50.84.

For the next year, analysts expect an EPS growth of 23.65% and a revenue growth 25.88% for TEM


Analysts
Analysts77.39
Price Target88.09 (73.27%)
EPS Next Y23.65%
Revenue Next Year25.88%

TEM Groups

Sector & Classification

TEM Financial Highlights

Over the last trailing twelve months TEM reported a non-GAAP Earnings per Share(EPS) of -0.61. The EPS increased by 75.89% compared to the year before.


Income Statements
Revenue(TTM)1.27B
Net Income(TTM)-245.03M
Industry RankSector Rank
PM (TTM) N/A
ROA -10.77%
ROE -49.87%
Debt/Equity 2.52
Chartmill High Growth Momentum
EPS Q2Q%77.78%
Sales Q2Q%82.98%
EPS 1Y (TTM)75.89%
Revenue 1Y (TTM)83.41%

TEM Ownership

Ownership
Inst Owners54.06%
Shares178.77M
Float105.30M
Ins Owners8.12%
Short Float %22.78%
Short Ratio4.24

TEM Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
TMO THERMO FISHER SCIENTIFIC INC19.06174.596B
DHR DANAHER CORP22.99135.34B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28125.6140.288B
A AGILENT TECHNOLOGIES INC16.8531.614B
WAT WATERS CORP20.4428.451B
IQV IQVIA HOLDINGS INC13.1427.68B
MTD METTLER-TOLEDO INTERNATIONAL25.7324.37B
ILMN ILLUMINA INC23.118.238B
WST WEST PHARMACEUTICAL SERVICES29.5517.307B
MEDP MEDPACE HOLDINGS INC26.1112.874B
RVTY REVVITY INC15.859.668B
TECH BIO-TECHNE CORP22.957.636B

About TEM

Company Profile

TEM logo image Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. The company is headquartered in Chicago, Illinois and currently employs 3,800 full-time employees. The company went IPO on 2025-05-30. The company offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. The company provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.

Company Info

IPO: 2025-05-30

TEMPUS AI INC-CL A

600 West Chicago Avenue, Suite 510

Chicago ILLINOIS US

Employees: 3800

TEM Company Website

Phone: 18335144187

TEMPUS AI INC-CL A / TEM FAQ

What does TEM do?

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. The company is headquartered in Chicago, Illinois and currently employs 3,800 full-time employees. The company went IPO on 2025-05-30. The company offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. The company provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.


Can you provide the latest stock price for TEMPUS AI INC-CL A?

The current stock price of TEM is 50.84 USD. The price decreased by -0.08% in the last trading session.


Does TEM stock pay dividends?

TEM does not pay a dividend.


What is the ChartMill technical and fundamental rating of TEM stock?

TEM has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the analyst forecast for TEM stock?

23 analysts have analysed TEM and the average price target is 88.09 USD. This implies a price increase of 73.27% is expected in the next year compared to the current price of 50.84.


When does TEMPUS AI INC-CL A (TEM) report earnings?

TEMPUS AI INC-CL A (TEM) will report earnings on 2026-05-01.


Can you provide the ownership details for TEM stock?

You can find the ownership structure of TEMPUS AI INC-CL A (TEM) on the Ownership tab.